Those with NASH or advanced liver fibrosis were predominantly older, male, and had higher BMI, AST, ALT, GGT, and fasting blood sugar levels, and higher presence of T2DM, hypertension, and metabolic syndrome compared with subjects with normal LS (P<0.001). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.